- CVS Pharmacy and its subsidiaries agreed to pay $315 million to resolve a Justice Department case alleging unlawful dispensing of medically unnecessary prescriptions of highly addictive opioids, officials said.
- The settlement resolves a lawsuit brought in 2024 that accused the healthcare giant of providing massive amounts of opioids and other controlled substances.
- CVS Health settles DOJ opioid prescription allegations, which involve claims of improper dispensing billed to Medicare.
- The settlement is part of a broader federal effort to hold companies accountable for alleged contributions to the U.S. addiction crisis.